IDEVAX shared highlights from work around Cancer Awareness Month in its August newsletter.
Public source
Publisher name
Public post
Our August newsletter is here! In this month’s newsletter, we’re sharing: 🔬 Highlights from our work around #CancerAwarenessMonth 🎓 Experiences and insights from the #…
Company
IDEVAX
An innovative developer and producer of medical devices offering accurate and reliable intradermal drug delivery devices
- Industry
- Medical Equipment Manufacturing
- Location
- Antwerp, BE
- Company size
- 11–50 employees
About IDEVAX
VAX-ID®, the heart of the Idevax company, is an award-winning patented drug delivery device platform suited for intradermal injection. The device can be preconfigured with a 32G needle as well as with a 27G needle to allow for different applications, with a penetration depth of 0.85 and 1.2mm respectively. The device is suited for accurate and reliable drug delivery of therapeutic and prophylactic medicinal substances in the dermal layer of the skin of both humans and animals.
See moreLatest activity
Latest activity from IDEVAX
5 signals
Research & Knowledge
IDEVAX's PhD student Merel Bartels is working with the Center for Oncological Research (CORE) at the University of Antwerp in collaboration with IDEVAX to support her PhD trajectory funded through the VLAIO Baekeland programme.
Research & Knowledge
IDEVAX biomedical scientist Merel Bartels officially kicked off her PhD trajectory at the University of Antwerp, focusing on improving immune cell therapies for cancer treatment.
People
IDEVAX shared more about Merel Bartels, a biomedical scientist continuing her PhD journey in her August newsletter.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Biocartis
Biocartis published a study by Antón-Peñalver et al. (2026) evaluating the use of the Idylla MTS assay on residual liquid-based cytology samples from EUS-FNA specimens in pancreatic cancer.
Research & Knowledge
Paxman Scalp Cooling
Paxman Scalp Cooling published an article inspired by Kia L.'s recent feature in Katie Couric Media exploring common questions Black women have about scalp cooling, including concerns around textured hair, treatment outcomes, and haircare during chemotherapy.
Research & Knowledge
Woodley Trial Solutions
Woodley Trial Solutions published an awareness article covering blood cancer symptoms, why early recognition matters, and advances being made through clinical research in September.
Research & Knowledge
Israel Cancer Research Fund (ICRF)
Israel Cancer Research Fund (ICRF) published its September newsletter featuring updates on 38 new cancer research grants, innovative approaches to understanding and treating cancer, and ICRF community news.
Research & Knowledge
BriaCell Therapeutics Corp.